{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:32:13Z","timestamp":1789450333419,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of Chin","doi-asserted-by":"crossref","award":["82171970, 82472018, 82402320"],"award-info":[{"award-number":["82171970, 82472018, 82402320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Beijing Science Foundation for Distinguished Young Scholars","award":["JQ21025"],"award-info":[{"award-number":["JQ21025"]}]},{"name":"the Beijing Municipal Science & Technology Commission","award":["Z221100007422027"],"award-info":[{"award-number":["Z221100007422027"]}]},{"name":"National High Level Hospital Clinical Research Funding (Interdisciplinary Research Project of Peking University First Hospital,","award":["2023IR17, 2024IR07"],"award-info":[{"award-number":["2023IR17, 2024IR07"]}]},{"name":"Scientific and Technological Achievements Transformation Incubation Guidance Fund Project of Peking University First Hospital","award":["2024CX20"],"award-info":[{"award-number":["2024CX20"]}]},{"name":"China Postdoctoral Science Foundation under Grant Number","award":["2024M750132"],"award-info":[{"award-number":["2024M750132"]}]},{"name":"Scientific Research Seed Fund of Peking University First Hospital","award":["2024SF64"],"award-info":[{"award-number":["2024SF64"]}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20240484725"],"award-info":[{"award-number":["20240484725"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00259-024-07036-7","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T02:29:48Z","timestamp":1735266588000},"page":"1791-1804","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["CD38-specific immunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studies"],"prefix":"10.1007","volume":"52","author":[{"given":"Wenpeng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8729-4547","authenticated-orcid":false,"given":"Lei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"7036_CR1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327:464\u201377.","journal-title":"JAMA"},{"key":"7036_CR2","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1158\/1078-0432.CCR-16-3192","volume":"23","author":"X Feng","year":"2017","unstructured":"Feng X, Zhang L, Acharya C, An G, Wen K, Qiu L, et al. Targeting CD38 suppresses induction and Function of T Regulatory Cells to mitigate immunosuppression in multiple myeloma. Clin Cancer Res. 2017;23:4290\u2013300.","journal-title":"Clin Cancer Res"},{"key":"7036_CR3","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1506348","volume":"373","author":"HM Lokhorst","year":"2015","unstructured":"Lokhorst HM, Plesner T, Laubach JP, Nahi H, Gimsing P, Hansson M, et al. Targeting CD38 with Daratumumab Monotherapy in multiple myeloma. N Engl J Med. 2015;373:1207\u201319.","journal-title":"N Engl J Med"},{"key":"7036_CR4","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/trf.17137","volume":"62","author":"B Chami","year":"2022","unstructured":"Chami B, Okuda M, Moayeri M, Pirenne F, Hidaka Y, Nambiar A, et al. Anti-CD38 monoclonal antibody interference with blood compatibility testing: differentiating isatuximab and daratumumab via functional epitope mapping. Transfusion. 2022;62:2334\u201348.","journal-title":"Transfusion"},{"key":"7036_CR5","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.1003032","volume":"186","author":"M de Weers","year":"2011","unstructured":"de Weers M, Tai Y-T, van der Veer MS, Bakker JM, Vink T, Jacobs DCH, et al. Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. J Immunol. 2011;186:1840\u20138.","journal-title":"J Immunol"},{"key":"7036_CR6","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s00259-018-3941-3","volume":"45","author":"L Kang","year":"2018","unstructured":"Kang L, Jiang D, England CG, Barnhart TE, Yu B, Rosenkrans ZT, et al. ImmunoPET imaging of CD38 in murine lymphoma models using 89Zr-labeled daratumumab. Eur J Nucl Med Mol Imaging. 2018;45:1372\u201381.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7036_CR7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/17474086.2023.2246651","volume":"16","author":"S Yadav","year":"2023","unstructured":"Yadav S, Gundeti S, Bhave A, Deb U, Dixit J, Mishra K. Role of daratumumab in the frontline management of multiple myeloma: a narrative review. Expert Rev Hematol. 2023;16:743\u201360.","journal-title":"Expert Rev Hematol"},{"key":"7036_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.seminhematol.2018.02.009","volume":"55","author":"N Pandit-Taskar","year":"2018","unstructured":"Pandit-Taskar N. Functional imaging methods for Assessment of minimal residual disease in multiple myeloma: current status and novel ImmunoPET based methods. Semin Hematol. 2018;55:22\u201332.","journal-title":"Semin Hematol"},{"key":"7036_CR9","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1182\/bloodadvances.2020002603","volume":"4","author":"A Krishnan","year":"2020","unstructured":"Krishnan A, Adhikarla V, Poku EK, Palmer J, Chaudhry A, Biglang-Awa VE, et al. Identifying CD38\u2009+\u2009cells in patients with multiple myeloma: first-in-human imaging using copper-64-labeled daratumumab. Blood Adv. 2020;4:5194\u2013202.","journal-title":"Blood Adv"},{"key":"7036_CR10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1148\/radiol.2020192621","volume":"295","author":"GA Ulaner","year":"2020","unstructured":"Ulaner GA, Sobol NB, O\u2019Donoghue JA, Kirov AS, Riedl CC, Min R, et al. CD38-targeted Immuno-PET of multiple myeloma: from Xenograft models to First-in-human imaging. Radiology. 2020;295:606\u201315.","journal-title":"Radiology"},{"key":"7036_CR11","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s00259-021-05218-1","volume":"48","author":"C Wang","year":"2021","unstructured":"Wang C, Chen Y, Hou YN, Liu Q, Zhang D, Zhao H, et al. ImmunoPET imaging of multiple myeloma with [68Ga]Ga-NOTA-Nb1053. Eur J Nucl Med Mol Imaging. 2021;48:2749\u201360.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7036_CR12","doi-asserted-by":"crossref","first-page":"2001879","DOI":"10.1002\/advs.202001879","volume":"8","author":"L Kang","year":"2021","unstructured":"Kang L, Li C, Rosenkrans ZT, Huo N, Chen Z, Ehlerding EB, et al. CD38-Targeted theranostics of lymphoma with 89Zr\/177Lu-Labeled daratumumab. Adv Sci (Weinh). 2021;8:2001879.","journal-title":"Adv Sci (Weinh)"},{"key":"7036_CR13","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s00259-021-05593-9","volume":"49","author":"L Kang","year":"2022","unstructured":"Kang L, Li C, Yang Q, Sutherlin L, Wang L, Chen Z, et al. 64Cu-labeled daratumumab F(ab\u2019)2 fragment enables early visualization of CD38-positive lymphoma. Eur J Nucl Med Mol Imaging. 2022;49:1470\u201381.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7036_CR14","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1021\/acs.molpharmaceut.2c00279","volume":"19","author":"L Shi","year":"2022","unstructured":"Shi L, Chen B, Liu T, Li L, Hu B, Li C, et al. 99mTc-CD3813: a nanobody-based single Photon Emission Computed Tomography Radiotracer with clinical potential for Myeloma Imaging and evaluation of CD38 expression. Mol Pharm. 2022;19:2583\u201394.","journal-title":"Mol Pharm"},{"key":"7036_CR15","doi-asserted-by":"crossref","unstructured":"Chen Z, Yang Q, Song L, Qiu Y, Wang T, Wu S et al. Enhanced Theranostic Efficacy of 89Zr and 177Lu-Labeled Aflibercept in Renal Cancer: A Viable Option for Clinical Practice. Mol Pharm. 2024.","DOI":"10.1021\/acs.molpharmaceut.4c00084"},{"key":"7036_CR16","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41423-021-00686-9","volume":"18","author":"JL Thangaraj","year":"2021","unstructured":"Thangaraj JL, Ahn S-Y, Jung S-H, Vo M-C, Chu T-H, Thi Phan M-T, et al. Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model. Cell Mol Immunol. 2021;18:1652\u201361.","journal-title":"Cell Mol Immunol"},{"key":"7036_CR17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12951-024-02317-7","volume":"22","author":"Z Li","year":"2024","unstructured":"Li Z, Huang W, Zhang M, Huo Y, Li F, Song L, et al. Minocycline-loaded nHAP\/PLGA microspheres for prevention of injury-related corneal angiogenesis. J Nanobiotechnol. 2024;22:134.","journal-title":"J Nanobiotechnol"},{"key":"7036_CR18","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s00259-023-06575-9","volume":"51","author":"Q Yang","year":"2024","unstructured":"Yang Q, Chen Z, Qiu Y, Huang W, Wang T, Song L, et al. Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer. Eur J Nucl Med Mol Imaging. 2024;51:1246\u201360.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7036_CR19","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E. OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023\u20137.","journal-title":"J Nucl Med"},{"key":"7036_CR20","first-page":"1","volume":"37","author":"The 2007 Recommendations of the International Commission on Radiological Protection","year":"2007","unstructured":"The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 2007;37:1\u2013332.","journal-title":"Ann ICRP"},{"key":"7036_CR21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00277-020-04374-y","volume":"100","author":"F Vozella","year":"2021","unstructured":"Vozella F, Siniscalchi A, Rizzo M, Za T, Antolino G, Coppetelli U, et al. Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group. Ann Hematol. 2021;100:1059\u201363.","journal-title":"Ann Hematol"},{"key":"7036_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2017-06-740944","volume":"131","author":"NWCJ van de Donk","year":"2018","unstructured":"van de Donk NWCJ, Richardson PG, Malavasi F. CD38 antibodies in multiple myeloma: back to the future. Blood. 2018;131:13\u201329.","journal-title":"Blood"},{"key":"7036_CR23","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1021\/acs.molpharmaceut.7b00298","volume":"14","author":"EB Ehlerding","year":"2017","unstructured":"Ehlerding EB, England CG, Jiang D, Graves SA, Kang L, Lacognata S, et al. CD38 as a PET imaging target in Lung Cancer. Mol Pharm. 2017;14:2400\u20136.","journal-title":"Mol Pharm"},{"key":"7036_CR24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1182\/blood-2017-09-807263","volume":"131","author":"E Caserta","year":"2018","unstructured":"Caserta E, Chea J, Minnix M, Poku EK, Viola D, Vonderfecht S, et al. Copper 64-labeled daratumumab as a PET\/CT imaging tracer for multiple myeloma. Blood. 2018;131:741\u20135.","journal-title":"Blood"},{"key":"7036_CR25","first-page":"6007","volume":"11","author":"S Li","year":"2019","unstructured":"Li S, England CG, Ehlerding EB, Kutyreff CJ, Engle JW, Jiang D, et al. ImmunoPET imaging of CD38 expression in hepatocellular carcinoma using 64Cu-labeled daratumumab. Am J Transl Res. 2019;11:6007\u201315.","journal-title":"Am J Transl Res"},{"key":"7036_CR26","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.3390\/ijms24065994","volume":"24","author":"B-K Jin","year":"2023","unstructured":"Jin B-K, Odongo S, Radwanska M, Magez S, Nanobodies. A review of Generation, Diagnostics and therapeutics. Int J Mol Sci. 2023;24:5994.","journal-title":"Int J Mol Sci"},{"key":"7036_CR27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2017-03-774422","volume":"130","author":"L Rasche","year":"2017","unstructured":"Rasche L, Angtuaco E, McDonald JE, Buros A, Stein C, Pawlyn C, et al. Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma. Blood. 2017;130:30\u20134.","journal-title":"Blood"},{"key":"7036_CR28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3109\/10428194.2012.740559","volume":"54","author":"J Hillengass","year":"2013","unstructured":"Hillengass J, Landgren O. Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging early myeloma. Leuk Lymphoma. 2013;54:1355\u201363.","journal-title":"Leuk Lymphoma"},{"key":"7036_CR29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s11307-024-01901-5","volume":"26","author":"A Zheleznyak","year":"2024","unstructured":"Zheleznyak A, Tang R, Duncan K, Manion B, Liang K, Xu B, et al. Development of New CD38 targeted peptides for Cancer Imaging. Mol Imaging Biol. 2024;26:738\u201352.","journal-title":"Mol Imaging Biol"},{"key":"7036_CR30","doi-asserted-by":"crossref","first-page":"e2308617","DOI":"10.1002\/advs.202308617","volume":"11","author":"AK Sharma","year":"2024","unstructured":"Sharma AK, Gupta K, Mishra A, Lofland G, Marsh I, Kumar D, et al. CD38-Specific Gallium-68 labeled peptide Radiotracer enables pharmacodynamic monitoring in multiple myeloma with PET. Adv Sci (Weinh). 2024;11:e2308617.","journal-title":"Adv Sci (Weinh)"},{"key":"7036_CR31","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1039\/D0CS00556H","volume":"50","author":"BM Cooper","year":"2021","unstructured":"Cooper BM, Iegre J, O\u2019 Donovan DH, \u00d6lweg\u00e5rd Halvarsson M, Spring DR. Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs). Chem Soc Rev. 2021;50:1480\u201394.","journal-title":"Chem Soc Rev"},{"key":"7036_CR32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/jcm13010264","volume":"13","author":"V Rodr\u00edguez-Laval","year":"2024","unstructured":"Rodr\u00edguez-Laval V, Lumbreras-Fern\u00e1ndez B, Aguado-Bueno B, G\u00f3mez-Le\u00f3n N. Imaging of multiple myeloma: Present and Future. J Clin Med. 2024;13:264.","journal-title":"J Clin Med"},{"key":"7036_CR33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/978-1-4939-8648-4_26","volume":"1827","author":"M Crauwels","year":"2018","unstructured":"Crauwels M, Massa S, Martin C, Betti C, Ballet S, Devoogdt N, et al. Site-specific Radioactive labeling of Nanobodies. Methods Mol Biol. 2018;1827:505\u201340.","journal-title":"Methods Mol Biol"},{"key":"7036_CR34","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1007\/s00259-023-06373-3","volume":"50","author":"X Ma","year":"2023","unstructured":"Ma X, Zhou X, Hu B, Li X, Yao M, Li L, et al. Preclinical evaluation and pilot clinical study of [68Ga]Ga-THP-APN09, a novel PD-L1 targeted nanobody radiotracer for rapid one-step radiolabeling and PET imaging. Eur J Nucl Med Mol Imaging. 2023;50:3838\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7036_CR35","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00259-023-06584-8","volume":"51","author":"M Zhang","year":"2024","unstructured":"Zhang M, Kang F, Xing T, Wang J, Ma T, Li G, et al. First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [68Ga]Ga-HER2 Affibody. Eur J Nucl Med Mol Imaging. 2024;51:1713\u201324.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-07036-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-07036-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-07036-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T19:50:38Z","timestamp":1742673038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-07036-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7036"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-07036-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Medical Ethics Committee of Peking University First Hospital (2024-084) and registered at ClinicalTrials.gov (NCT06385652) and the Animal Committee of Peking University First Hospital (No. J2023059). Patients signed informed consent regarding publishing their data and photographs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The requirement for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}